<DOC>
	<DOC>NCT02569164</DOC>
	<brief_summary>PCO patients will be assessed clinically,urine &amp; blood samples will be tested. Systolic &amp; diastolic blood pressure, serum glucose &amp; insulin levels, lipid profile, C-reactive protein, complete hormonal profile, and Urinary albumin excretion will be measured.</brief_summary>
	<brief_title>Cardiovascular Risks and Urinary Albumin Excretion(UAE) in Polycystic Ovarian Syndrome (PCO)</brief_title>
	<detailed_description>PCO patients with 2 of 3 criteria: oligo- or anovulation ; hyperandrogenism &amp;polycystic ovaries. Exclusion criteria: pregnancy, diabetes, hypertension , adrenal &amp; thyroid dysfunction. Blood samples after overnight fast (8hrs) at day 2 or 3 of menstrual cycle. Serum concentration of follicle stimulating hormone (FSH), luteinizing hormone (LH), prolactin, total testosterone &amp; sex hormone binding globulin, serum 17-hydroxy (OH) progesterone &amp; dehydroepiandrosterone sulfate will be measured. Oral glucose tolerance test &amp; plasma insulin levels will be measured. Total cholesterol, triglycerides, high&amp; low density lipoproteins. Urinary albumin will be measured&amp; all the data will be analysed.</detailed_description>
	<criteria>PCO patients pregnancy diabetes hypertension adrenal dysfunction thyroid dysfunction</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>